GSK’s kidney disease anemia drug approved in Japan, taking on Astellas’ rival

GSK’s kidney disease anemia drug approved in Japan, taking on Astellas’ rival

Source: 
Pharmaforum
snippet: 

GlaxoSmithKline’s drug for anemia caused by chronic kidney disease daprodustat has been approved in Japan, taking on a recently approved rival from Astellas.